H.C. Wainwright raised the firm’s price target on Sol-Gel Technologies (SLGL) to $110 from $50 and keeps a Buy rating on the shares. The firm now anticipates that SGT-610 may generate peak annual sales approaching $640M by the mid-2030s.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLGL:
- Sol-Gel: SGT-610 as Core Value Driver Underpins $50 Target and Buy Rating Despite Pipeline Setbacks
- Sol-Gel Technologies Updates Clinical Pipeline Following Phase 1b Results
- Sol-Gel decides not to advance SGT-210 development in Darier disease
- One new option listing and fifteen option delistings on November 24th
- Sol-Gel Technologies Announces Q3 2025 Financial Results and Strategic Developments